Collegium Pharmaceutical Q3 Adj EPS $1.34 Vs $1.10 Prior Year, Sales $136.71M Miss $138.53M Estimate
Portfolio Pulse from Benzinga Newsdesk
Collegium Pharmaceutical reported Q3 adjusted earnings of $1.34 per share, a 21.82% increase from the same period last year. However, the company's quarterly sales of $136.71 million missed the analyst consensus estimate of $138.53 million by 1.31%.
November 07, 2023 | 9:44 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Collegium Pharmaceutical's Q3 earnings per share increased by 21.82% year-over-year, but sales missed analyst estimates by 1.31%.
While the company's earnings per share increased significantly, the missed sales estimate could potentially offset the positive impact of the earnings beat on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100